| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = $999,999 ) |
| | 2020 | 2020 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 003 | 3 | NIH | 8/20/2020 | $999,999 |
| | 2020 | 2020 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 002 | 3 | NIH | 8/18/2020 | $999,999 |
| | 2020 | 2020 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 003 | 3 | NIH | 8/20/2020 | -$999,999 |
| | 2020 | 2019 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 000 | 2 | NIH | 11/1/2019 | $0 |
| | 2020 | 2019 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 001 | 2 | NIH | 6/9/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,156,334 ) |
| | 2019 | 2019 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 002 | 2 | NIH | 8/22/2019 | $0 |
| | 2019 | 2019 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 001 | 2 | NIH | 8/19/2019 | $999,999 |
| | 2019 | 2019 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 003 | 2 | NIH | 9/20/2019 | $156,335 |
| | 2019 | 2018 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 000 | 1 | NIH | 8/9/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $300,000 ) |
| | 2018 | 2018 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 001 | 1 | NIH | 9/17/2018 | -$300,000 |
| | 2018 | 2018 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 000 | 1 | NIH | 4/16/2018 | $300,000 |
| | 2018 | 2018 | LACERTA THERAPEUTICS, INC. | 12085 RESEARCH DR STE 108 | ALACHUA | FL | 32615-6837 | ALACHUA | USA | R42CA228875 | Targeting glioblastoma stem-like cells with custom-designed viral vectors | 001 | 1 | NIH | 9/17/2018 | $300,000 |
|
|
